instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | ACITRETIN, CLARITHROMYCIN | DrugsGivenReaction | CC BY | 33718249 | 20,874,907 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | ACITRETIN, CLARITHROMYCIN | DrugsGivenReaction | CC BY | 33718249 | 19,083,671 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dry skin'. | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | ACITRETIN, CLARITHROMYCIN | DrugsGivenReaction | CC BY | 33718249 | 19,083,671 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Idiopathic intracranial hypertension'. | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | ACITRETIN, CLARITHROMYCIN | DrugsGivenReaction | CC BY | 33718249 | 19,083,671 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lip dry'. | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | ACITRETIN, CLARITHROMYCIN | DrugsGivenReaction | CC BY | 33718249 | 19,083,671 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | ACITRETIN, CLARITHROMYCIN | DrugsGivenReaction | CC BY | 33718249 | 19,083,671 | 2021 |
What was the administration route of drug 'ACITRETIN'? | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | Oral | DrugAdministrationRoute | CC BY | 33718249 | 19,083,671 | 2021 |
What was the administration route of drug 'CLARITHROMYCIN'? | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | Oral | DrugAdministrationRoute | CC BY | 33718249 | 19,083,671 | 2021 |
What was the dosage of drug 'ACITRETIN'? | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | 30 MILLIGRAM DAILY; | DrugDosageText | CC BY | 33718249 | 19,083,671 | 2021 |
What was the dosage of drug 'CLARITHROMYCIN'? | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | 500 MILLIGRAM DAILY; | DrugDosageText | CC BY | 33718249 | 19,083,671 | 2021 |
What was the outcome of reaction 'Dry skin'? | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | Recovered | ReactionOutcome | CC BY | 33718249 | 19,083,671 | 2021 |
What was the outcome of reaction 'Idiopathic intracranial hypertension'? | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | Recovered | ReactionOutcome | CC BY | 33718249 | 19,083,671 | 2021 |
What was the outcome of reaction 'Lip dry'? | Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.
Few studies have evaluated acitretin as a primary treatment for cutaneous squamous cell carcinoma (CSCC). We report, for the first time, three cases of CSCC successfully treated w... | Recovered | ReactionOutcome | CC BY | 33718249 | 19,083,671 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Melaena'. | Accessory Splenic Artery Causing Massive Gastrointestinal Bleed.
The presentation of an upper gastrointestinal bleed secondary to an accessory splenic artery is a rare circumstance described only in 2 previous case reports. This report is the first to describe an upper gastrointestinal bleed consequent of a submucosal ... | ASPIRIN, IBUPROFEN, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33718509 | 20,904,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper gastrointestinal haemorrhage'. | Accessory Splenic Artery Causing Massive Gastrointestinal Bleed.
The presentation of an upper gastrointestinal bleed secondary to an accessory splenic artery is a rare circumstance described only in 2 previous case reports. This report is the first to describe an upper gastrointestinal bleed consequent of a submucosal ... | ASPIRIN, IBUPROFEN, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33718509 | 20,904,986 | 2021-03 |
What was the outcome of reaction 'Melaena'? | Accessory Splenic Artery Causing Massive Gastrointestinal Bleed.
The presentation of an upper gastrointestinal bleed secondary to an accessory splenic artery is a rare circumstance described only in 2 previous case reports. This report is the first to describe an upper gastrointestinal bleed consequent of a submucosal ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33718509 | 20,904,986 | 2021-03 |
What was the outcome of reaction 'Upper gastrointestinal haemorrhage'? | Accessory Splenic Artery Causing Massive Gastrointestinal Bleed.
The presentation of an upper gastrointestinal bleed secondary to an accessory splenic artery is a rare circumstance described only in 2 previous case reports. This report is the first to describe an upper gastrointestinal bleed consequent of a submucosal ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33718509 | 20,904,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypocalcaemia'. | Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.
To evaluate a case of pembrolizumab-induced hypoparathyroidism leading to hypocalcemia.
The diagnostic tests performed included calcium and parathyroid hormone level detection and calcium-sensing receptor gene analysis.
A 71-year-old Caucasian man was d... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33718603 | 20,140,584 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoparathyroidism'. | Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.
To evaluate a case of pembrolizumab-induced hypoparathyroidism leading to hypocalcemia.
The diagnostic tests performed included calcium and parathyroid hormone level detection and calcium-sensing receptor gene analysis.
A 71-year-old Caucasian man was d... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33718603 | 20,140,584 | 2021 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.
To evaluate a case of pembrolizumab-induced hypoparathyroidism leading to hypocalcemia.
The diagnostic tests performed included calcium and parathyroid hormone level detection and calcium-sensing receptor gene analysis.
A 71-year-old Caucasian man was d... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33718603 | 20,140,584 | 2021 |
What was the outcome of reaction 'Hypocalcaemia'? | Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.
To evaluate a case of pembrolizumab-induced hypoparathyroidism leading to hypocalcemia.
The diagnostic tests performed included calcium and parathyroid hormone level detection and calcium-sensing receptor gene analysis.
A 71-year-old Caucasian man was d... | Recovering | ReactionOutcome | CC BY | 33718603 | 20,140,584 | 2021 |
What was the outcome of reaction 'Hypoparathyroidism'? | Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.
To evaluate a case of pembrolizumab-induced hypoparathyroidism leading to hypocalcemia.
The diagnostic tests performed included calcium and parathyroid hormone level detection and calcium-sensing receptor gene analysis.
A 71-year-old Caucasian man was d... | Recovering | ReactionOutcome | CC BY | 33718603 | 20,140,584 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiosarcoma metastatic'. | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiosarcoma'. | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | CYCLOSPORINE, MYCOPHENOLIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33718686 | 9,506,483 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoptysis'. | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemothorax'. | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to bone'. | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lung'. | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral ischaemia'. | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
What was the outcome of reaction 'Angiosarcoma metastatic'? | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | Fatal | ReactionOutcome | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
What was the outcome of reaction 'Angiosarcoma'? | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | Fatal | ReactionOutcome | CC BY-NC-ND | 33718686 | 9,506,483 | 2021-03 |
What was the outcome of reaction 'Haemothorax'? | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | Fatal | ReactionOutcome | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
What was the outcome of reaction 'Metastases to lung'? | Angiosarcoma in arteriovenous fistula after kidney transplantation.
Angiosarcoma is a rare complication of both functioning and nonfunctioning fistulas. It is an aggressive soft tissue sarcoma arising from vascular or lymphatic endothelial cells. We report a case of angiosarcoma from a nonfunctional fistula in a kidney... | Fatal | ReactionOutcome | CC BY-NC-ND | 33718686 | 19,581,913 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angioedema'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Constipation'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dry mouth'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Feeling jittery'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Formication'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrooesophageal reflux disease'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hallucination'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inadequate analgesia'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Influenza like illness'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Insomnia'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle twitching'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nightmare'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Orthostatic hypotension'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suicidal ideation'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tinnitus'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary retention'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vision blurred'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Withdrawal syndrome'. | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated wi... | CODEINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33718782 | 18,874,449 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia.
Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as multiple mye... | BORTEZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33718795 | 19,459,856 | 2021-02 |
What was the administration route of drug 'LENALIDOMIDE'? | Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia.
Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as multiple mye... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33718795 | 19,459,856 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac tamponade'. | Timed Controlled Repeated Rotation of the CAR-170-C NXSTAGE Chronic Cartridge Hemodialysis Filter: A Novel Approach to Enabling Heparin-Free Frequent Daily Home Hemodialysis.
Heparin-free hemodialysis is often warranted in postoperative states, bleeding diathesis, and critically ill patients. Conventionally, this is ac... | WARFARIN SODIUM | DrugsGivenReaction | CC BY-NC-ND | 33718796 | 18,556,293 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial haemorrhage'. | Timed Controlled Repeated Rotation of the CAR-170-C NXSTAGE Chronic Cartridge Hemodialysis Filter: A Novel Approach to Enabling Heparin-Free Frequent Daily Home Hemodialysis.
Heparin-free hemodialysis is often warranted in postoperative states, bleeding diathesis, and critically ill patients. Conventionally, this is ac... | WARFARIN SODIUM | DrugsGivenReaction | CC BY-NC-ND | 33718796 | 18,556,293 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endocarditis histoplasma'. | Prosthetic Joint Infections Due to Histoplasma capsulatum: A Report of 3 Cases.
Histoplasma capsulatum causes pneumonia and multisystemic disease in humans. Musculoskeletal involvement in histoplasmosis is most often tenosynovitis and rarely septic arthritis. Even more uncommon is the involvement of prosthetic joints. ... | ETANERCEPT, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33718797 | 19,466,418 | 2021-02 |
What was the outcome of reaction 'Arthritis infective'? | Prosthetic Joint Infections Due to Histoplasma capsulatum: A Report of 3 Cases.
Histoplasma capsulatum causes pneumonia and multisystemic disease in humans. Musculoskeletal involvement in histoplasmosis is most often tenosynovitis and rarely septic arthritis. Even more uncommon is the involvement of prosthetic joints. ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33718797 | 19,471,700 | 2021-02 |
What was the outcome of reaction 'Device failure'? | Prosthetic Joint Infections Due to Histoplasma capsulatum: A Report of 3 Cases.
Histoplasma capsulatum causes pneumonia and multisystemic disease in humans. Musculoskeletal involvement in histoplasmosis is most often tenosynovitis and rarely septic arthritis. Even more uncommon is the involvement of prosthetic joints. ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33718797 | 19,471,700 | 2021-02 |
What was the outcome of reaction 'Device related infection'? | Prosthetic Joint Infections Due to Histoplasma capsulatum: A Report of 3 Cases.
Histoplasma capsulatum causes pneumonia and multisystemic disease in humans. Musculoskeletal involvement in histoplasmosis is most often tenosynovitis and rarely septic arthritis. Even more uncommon is the involvement of prosthetic joints. ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33718797 | 19,471,700 | 2021-02 |
What was the outcome of reaction 'Histoplasmosis'? | Prosthetic Joint Infections Due to Histoplasma capsulatum: A Report of 3 Cases.
Histoplasma capsulatum causes pneumonia and multisystemic disease in humans. Musculoskeletal involvement in histoplasmosis is most often tenosynovitis and rarely septic arthritis. Even more uncommon is the involvement of prosthetic joints. ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33718797 | 19,471,700 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma.
A 62-year-old man presented with a history of atypical meningioma (World Health Organization grade II) and recurrent as anaplastic meningioma (World Health Organization grade III). His previous treatments included multiple surgical resections,... | BEVACIZUMAB, EVEROLIMUS, HYDROXYUREA, OCTREOTIDE | DrugsGivenReaction | CC BY-NC-ND | 33718799 | 19,472,503 | 2021-02 |
What was the outcome of reaction 'Drug ineffective'? | Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma.
A 62-year-old man presented with a history of atypical meningioma (World Health Organization grade II) and recurrent as anaplastic meningioma (World Health Organization grade III). His previous treatments included multiple surgical resections,... | Fatal | ReactionOutcome | CC BY-NC-ND | 33718799 | 19,472,503 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cutaneous sarcoidosis'. | Combined pulsed-dye laser and medical therapy for treatment of cutaneous sarcoidosis lesions: a case report.
Sarcoidosis is a systemic granulomatous disease of unknown etiology that most frequently occurs in the lungs. However, cutaneous lesions are often the primary sign. Cutaneous sarcoidosis is difficult to treat, a... | ACITRETIN, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY-NC | 33719667 | 19,146,020 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Combined pulsed-dye laser and medical therapy for treatment of cutaneous sarcoidosis lesions: a case report.
Sarcoidosis is a systemic granulomatous disease of unknown etiology that most frequently occurs in the lungs. However, cutaneous lesions are often the primary sign. Cutaneous sarcoidosis is difficult to treat, a... | ACITRETIN, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY-NC | 33719667 | 19,146,020 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Combined pulsed-dye laser and medical therapy for treatment of cutaneous sarcoidosis lesions: a case report.
Sarcoidosis is a systemic granulomatous disease of unknown etiology that most frequently occurs in the lungs. However, cutaneous lesions are often the primary sign. Cutaneous sarcoidosis is difficult to treat, a... | ACITRETIN, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY-NC | 33719667 | 19,146,020 | 2021-03 |
What was the administration route of drug 'ACITRETIN'? | Combined pulsed-dye laser and medical therapy for treatment of cutaneous sarcoidosis lesions: a case report.
Sarcoidosis is a systemic granulomatous disease of unknown etiology that most frequently occurs in the lungs. However, cutaneous lesions are often the primary sign. Cutaneous sarcoidosis is difficult to treat, a... | Oral | DrugAdministrationRoute | CC BY-NC | 33719667 | 19,146,020 | 2021-03 |
What was the outcome of reaction 'Cutaneous sarcoidosis'? | Combined pulsed-dye laser and medical therapy for treatment of cutaneous sarcoidosis lesions: a case report.
Sarcoidosis is a systemic granulomatous disease of unknown etiology that most frequently occurs in the lungs. However, cutaneous lesions are often the primary sign. Cutaneous sarcoidosis is difficult to treat, a... | Not recovered | ReactionOutcome | CC BY-NC | 33719667 | 19,146,020 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | METHYLPREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33721094 | 19,059,238 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | METHYLPREDNISOLONE SODIUM SUCCINATE, RITUXIMAB | DrugsGivenReaction | CC BY | 33721094 | 19,082,833 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | METHYLPREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33721094 | 19,059,614 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory disorder'. | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | METHYLPREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33721094 | 19,064,815 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | METHYLPREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33721094 | 19,059,614 | 2021-05 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33721094 | 19,082,833 | 2021-05 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33721094 | 19,059,614 | 2021-05 |
What was the administration route of drug 'RITUXIMAB'? | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33721094 | 19,059,614 | 2021-05 |
What was the outcome of reaction 'Acute myocardial infarction'? | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | Fatal | ReactionOutcome | CC BY | 33721094 | 19,059,238 | 2021-05 |
What was the outcome of reaction 'Death'? | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | Fatal | ReactionOutcome | CC BY | 33721094 | 19,082,833 | 2021-05 |
What was the outcome of reaction 'Pneumonitis'? | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | Fatal | ReactionOutcome | CC BY | 33721094 | 19,059,614 | 2021-05 |
What was the outcome of reaction 'Respiratory failure'? | A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with exi... | Fatal | ReactionOutcome | CC BY | 33721094 | 19,059,614 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradypnoea'. | Extracorporeal cardiopulmonary resuscitation for severe chloroquine intoxication in a child - a case report.
BACKGROUND
Chloroquine use has increased worldwide recently in the setting of experimental treatment for the novel coronavirus disease (Covid-19). Nevertheless, in case of chloroquine intoxication, it can be lif... | CHLOROQUINE | DrugsGivenReaction | CC BY | 33722251 | 19,131,661 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Extracorporeal cardiopulmonary resuscitation for severe chloroquine intoxication in a child - a case report.
BACKGROUND
Chloroquine use has increased worldwide recently in the setting of experimental treatment for the novel coronavirus disease (Covid-19). Nevertheless, in case of chloroquine intoxication, it can be lif... | CHLOROQUINE | DrugsGivenReaction | CC BY | 33722251 | 19,131,661 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Extracorporeal cardiopulmonary resuscitation for severe chloroquine intoxication in a child - a case report.
BACKGROUND
Chloroquine use has increased worldwide recently in the setting of experimental treatment for the novel coronavirus disease (Covid-19). Nevertheless, in case of chloroquine intoxication, it can be lif... | CHLOROQUINE | DrugsGivenReaction | CC BY | 33722251 | 19,131,661 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Circulatory collapse'. | Extracorporeal cardiopulmonary resuscitation for severe chloroquine intoxication in a child - a case report.
BACKGROUND
Chloroquine use has increased worldwide recently in the setting of experimental treatment for the novel coronavirus disease (Covid-19). Nevertheless, in case of chloroquine intoxication, it can be lif... | CHLOROQUINE | DrugsGivenReaction | CC BY | 33722251 | 19,131,661 | 2021-03-15 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.